Bio-Trials to Complement Existing Quintiles Latin American Organization
RESEARCH TRIANGLE PARK, N.C., Oct. 30 /PRNewswire/ -- Quintiles
Transnational Corp. today announced that its Latin American subsidiary has
purchased Bio-Trials, a leading Central American Clinical Research
Organization (CRO) with headquarters in Panama and offices in Costa Rica,
Guatemala, Ecuador and Peru.
Bio-Trials provides clinical monitoring, clinical site coordination,
regulatory support, study management and supply distribution services. It
has conducted about 30 clinical trials in 10 Central and South American
countries, and its customers have included a number of major pharmaceutical
companies and global CROs.
"The acquisition of Bio-Trials gives Quintiles an experienced, well-
established team as well as access to an experienced network of independent
investigators in the increasingly important Central American region," said
Jeff Thomis, President of Global Clinical Development Services for
Quintiles. "Our customers are increasingly including Central America as
part of their global drug development program. The Bio-Trials team will be
a welcome addition to our Latin America group."
In addition to its offices, Bio-Trials has supply distribution points
in Panama, Costa Rica, Guatemala and Peru.
About Quintiles Latin America
Quintiles Latin America was founded in 1995 and now has nearly 600
employees in six countries, with headquarters in Argentina, providing
project management, clinical trial monitoring, regulatory, drug safety,
site management, quality assurance, central laboratory and clinical trial
supplies services. Quintiles Latin America has conducted more than 300
studies involving more than 30,000 patients.
About Quintiles Transnational
Quintiles Transnational Corp. is powering the next generation of
healthcare by providing a broad range of professional services in drug
development, financial partnering and commercialization for the
pharmaceutical, biotechnology and healthcare industries. With more than
19,000 employees and offices in more than 50 countries, it is focused on
providing customer-centric solutions that are the gold standard of the
industry. For more information, please visit the company's Web site at
http://www.qtrn.com.
SOURCE Quintiles Transnational Corp.
 back to top
Related links:
http://www.qtrn.com
CONTACT:
Dick Jones, Media Relations, +1-919-998-2091,
media.info@quintiles.com, or Greg Connors, Investor Relations,
+1-919-998-2000, invest@quintiles.com
|
